NCT03091738View on ClinicalTrials.gov

Ramelteon for Treatment of Insomnia in Cirrhosis

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

October 1, 2018

Study Completion Date

October 1, 2018

Conditions
Cirrhosis
Interventions
DRUG

Ramelteon Pill

Patients with compensated cirrhosis and insomnia will be provided ramelteon

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Virginia Commonwealth University

OTHER

NCT03091738 - Ramelteon for Treatment of Insomnia in Cirrhosis | Biotech Hunter | Biotech Hunter